Antibiotic (ATB) therapy and outcome from Nivolumab (N) in metastatic Renal Cell Carcinoma (mRCC) patients (pts): Results of the GETUGAFU 26 NIVOREN Multicentric Phase II Study.
Nivolumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Antibiotic (ATB) therapy and outcome from Nivolumab (N) in metastatic Renal Cell Carcinoma (mRCC) patients (pts): Results of the GETUGAFU 26 NIVOREN Multicentric Phase II Study. ### Output: Nivolumab